Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The aim of this prospective, randomized, double-blind, intraindividual split face study will
be to compare onabotulinumtoxinA to incobotulinumtoxinA for the correction of facial wrinkles
using a 1:1 dose ratio.
Phase:
N/A
Details
Lead Sponsor:
YMD Eye and Face
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA